“…These relatively simple compounds were converted to derivatives bearing 1-arylsulfonyl-1,2,3-triazole-4-yl moiety. Such a structural design was inspired by our previous results showing that arylsulfonamido 17 arylsulfonato, 18 and (bphenylsulfonyl)ethylthio 8 substituted benzosiloxaboroles (Scheme 1, general structures III, IV, and V, respectively) exhibit high activity against the Gram-positive cocci such as methicillin-sensitive Staphylococcus aureus (MSSA), methicillinresistant S. aureus (MRSA), Enterococcus faecalis and Enterococcus faecium. Based on the presented literature background, [10][11][12][13][14][15][16] we assumed that the introduction of 1,2,3-triazole spacer between arylsulfonyl group and benzosiloxaborole might have further positive impact on the antimicrobial potency.…”